AGP Executive Report
Last update: 8 hours agoGenomics Dispute: The US barred imports from three Chinese biotech firms, including BGI, over alleged forced-labor links in Xinjiang. Beijing rejected the allegations, escalating tensions in biotech trade. Research and Innovation: Chinese cancer drugmakers drew attention at a global oncology congress, while China approved a brain implant designed to help people with paralysis use their hands. Healthcare Cooperation: Chinese and Swiss businesses discussed collaboration in biomedicine and AI; separately, a Chinese hospital ship provided care in Ghana. Health System Pressures: China’s old-age dependency ratio surpassed its child dependency ratio for the first time in 2025, sharpening the challenge of meeting older people’s care needs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
